This study was designed to assess G protein function in mononuclear leukocytes (MNL) of patients with congestive heart failure (CHF). MNL membranes were ADP-ribosylated in vitro in the presence of pertussis or cholera toxin. The amount of pertussis toxin substrates did not differ significantly between CHF patients (6,100 ±224 fmol/mg, n =23) and age-matched healthy control subjects (5,812 ±972 fmol/mg protein, n = 19). Among the CHF patients, no differences were observed between those with idiopathic and ischemic CHF. The amount of cholera toxin substrates also did not differ significantly between CHF patients (7,522±1,405 fmol/mg protein, n=11) and control subjects (5,654±707 fmol/mg protein, n=14). Moreover, basal and isoproterenol-and prostaglandin El-stimulated cyclic AMP (cAMP) accumulation in MNL was similar in control subjects and patients. To detect more subtle alterations of the cAMPgenerating system, we incubated anticoagulated blood with 250-400 ng/ml pertussis toxin for 4 hours at 370 C. This treatment completely ADP-ribosylated the MNL pertussis toxin substrates. Incubation with pertussis toxin did not change basal or prostaglandin E1-stimulated cAMP generation in MNL of control subjects, but it significantly enhanced stimulated generation (443 ±44 vs. 643 ±93 pmol/107 cells, p<0.025) in MNL of CHF patients. This enhancement was most pronounced in the most severely ill patients (New York Heart Association class lY) and correlated with plasma norepinephrine levels, another marker of CHF severity (r=0.798, n = 11, p <0.01). Isoproterenol-stimulated cAMP generation, which was much weaker than that produced by prostaglandin E1, was enhanced only in patients in class IV. We conclude that despite apparently unaltered amounts of subunits identifiable by ADP ribosylation with pertussis toxin, MNL of CHF patients appear to have enhanced functional activity (i.e., inhibition of cAMP formation) by these substrates. Thus, incubation of MNL with pertussis toxin reveals a tonic inhibition of cAMP generation in cells of CHF patients. The results suggest that incubation of whole blood with pertussis toxin and subsequent assessment of cAMP accumulation in MNL provide a useful way to examine G protein function in patients with cardiovascular disease. (Circulation 1990;81:1198-1204 I notropic responsiveness is markedly reduced in the hearts of experimental animals and patients suffering from congestive heart failure (CHF). A reduced density of receptors for catecholamines (,3-adrenergic) 
I notropic responsiveness is markedly reduced in the hearts of experimental animals and patients suffering from congestive heart failure (CHF). A reduced density of receptors for catecholamines (,3-adrenergic) and vasoactive intestinal polypeptide might partly explain this reduction in inotropy.'-4An increasing body of evidence suggests that alterations of the signal transduction pathways by which these receptors activate cellular responses also contribute to the impairment of cardiac contractility. Specifically, alterations of cardiac GTP-binding (G) pro- teins have been demonstrated in CHF,5-10 but the published data are unsatisfactory in several ways. 1) It is not clear whether the number or activity of G proteins is altered. 2) Previous data in human hearts were exclusively obtained from patients with endstage CHF undergoing cardiac transplantation; such data do not allow conclusions on the role of G protein alterations during the development of CHF.
3) The possibility that alterations of signal transduction occur in tissues other than the heart has not been extensively tested in CHF.
Therefore, we studied signal transduction in an extracardiac tissue, in circulating mononuclear cells (MNL), in patients with different stages of CHF, and in age-matched healthy control subjects. For this purpose, we developed a novel assay that involves treatment of intact cells with pertussis toxin and subsequent assessment of cyclic AMP (cAMP) accumulation. Pertussis toxin catalyzes the transfer of an ADP-ribose moiety from NAD to the a-subunit of a variety of G proteins"l and thereby can inhibit the activity of these proteins.
One of these pertussis toxin-sensitive G proteins is Gi, so named because it inhibits the activity of adenylyl cyclase. In this study, we show that patients with CHF appear to have enhanced activity of Gi.
Methods

Materials
[32P]NAD and [3H]cAMP were obtained from New England Nuclear (Boston, Massachusetts). Pertussis and cholera toxins were obtained from List Laboratories (Campbell, California). All other reagents were from standard sources and of the highest commercially available purity grade. Measurement and concentration-response experiments for NAD and cholera toxin were performed initially to ensure that ribosylation was maximal under these conditions. We also tested whether addition of exogenous ADP ribosylation factor was necessary for maximal ribosylation of G,. For this purpose, we prepared membranes from cyc-S49 cells (which lack GQ) and performed the ribosylation experiments in the presence and absence of these membranes. Our experiments showed that ADP ribosylation factor was not necessary to achieve maximal ribosylation in control subjects or in CHF patients (data not shown). Fur- thermore, detergent extraction of the membrane tissue was not required for maximal labeling.
The reaction for labeling of both GQ, and Gi, was terminated by adding 38 ,ul gel sample buffer containing 125 mM Tris (pH 6.9), 20% glycerol, 4% sodium dodecyl sulfate, and 10% 2-mercaptoethanol and bromophenol blue. The samples were boiled for 5 minutes, loaded on slab gels (running gel 4% and stacking gel 17% acrylamide), and run overnight at a constant current of 20 mA. The gels were then stained with Coomassie blue, destained, and dried for 2 hours on filter paper with a gel dryer (Bio-Rad Labs, Richmond, California). Autoradiography of the dried gels was performed at -70°C for 3 days with Kodak X-omat XAR-5 film in the presence of a lightning-plus-intensifying screen. Molecular weight standards were run in each gel, and the autoradiograms and the respective original Coomassie-stained gel were aligned to identify the apparent molecular weight of the ADP-ribosylated proteins.
To Patients. Thirteen male patients (age range, 56-73 years; mean, 59±5 years) with CHF (NYHA classes II-IV) were studied. Each patient had a clinical history of CHF for at least 6 months. Six patients were classified as having ischemia and seven as idiopathic cardiomyopathy. The left ventricular ejection fraction, determined by equilibrium-gated radionuclide ventriculography, averaged 25±3%. All patients were receiving digitalis, diuretics, and at least one vasodilator (nitrates in 12, hydralazine in two, and angiotensin converting enzyme inhibitors in seven patients). All cardiac medications were withheld for [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] hours before the study. Eight healthy men (age range, 32-76 years; mean, 61±5 years) who had no history of cardiac impairment served as control subjects.
Incubation of blood with pertussis toxin. Subjects above. Eighty milliliters of blood was obtained and placed in tubes containing EDTA (5 mM final) and incubated with or without pertussis toxin (250-400 ng/ml) for 4 hours at 370 C in an incubator with 5%
CO2. The concentration of pertussis toxin needed to completely ribosylate the aAirra-subunit of G-in these intact cell studies varied depending on the age and lot number of pertussis toxin. cAMP accumulation. MNL were prepared from the blood after the incubation with pertussis toxin as described above. cAMP accumulation in these MNL was then assessed by adding 0.1 ml cells (2-lOx 105, ice cold) to 0.9 ml Dulbecco's modified Eagle's medium supplemented with 20 mM HEPES and 1 mg/ml bovine serum albumin at 370 C. The final reaction mixture contained 100 ,uM isobutylmethylxanthine and 100 ,uM Ro 20-1724 (to inhibit cyclic nucleotide phosphodiesterase), 10 ,ug/ml each of superoxide dismutase and catalase (to prevent oxidation of the isoproterenol17), and in some tubes 10 (Figure 1 ). The basal cAMP accumulation in MNL was not significantly different between pertussis toxintreated and untreated cells in control subjects and CHF patients ( Figure 5 ). The isoproterenol-and PGE1-stimulated cAMP accumulation in MNL from healthy control subjects was not significantly different between pertussis toxin-treated and untreated cells ( Figure 6 ). In contrast, incubation with pertussis toxin significantly increased PGEI-stimulated cAMP accumulation in MNL from patients with CHF (from 443±44 to 643±93 pmol/107 cells; n=15, p<0.025, Figure 6 ). Incubation of MNL with pertussis toxin did not significantly increase isoproterenol-stimulated cAMP accumulation in MNL from patients with CHF (from 234±35 to 254±62 pmol/107 cells, Figure 6 ). We did not observe any relation between basal or stimulated cAMP accumulation and age in normal subjects or patients with CHF either before or after pertussis toxin treatment (data not shown).
We used two approaches to determine whether the alteration of cAMP accumulation after pertussis toxin treatment were related to the severity of CHF. First, each of the four CHF patients in NYHA class IV had greater cAMP accumulation in response to isoproterenol and PGE1 in MNL incubated with pertussis toxin (p =0.29 and p =0.03 by paired t test, respectively, data not shown). Second, because plasma norepinephrine levels have been used as a prognostic indicator in heart failure, we also subdivided our patients according to this parameter. Isoproterenol-stimulated cAMP generation after pertussis toxin treatment was significantly elevated only in the group with plasma norepinephrine values greater than 700 pg/ml but not in the groups with lower plasma catecholamine levels (p=0.02, Figure  7 ). PGE1-stimulated cAMP generation was enhanced after pertussis toxin treatment in all three groups (p=0.02), and the enhancement was greater at higher plasma catecholamine levels ( Figure 7 ). This finding was further documented by comparing plasma norepinephrine levels and the enhancement of PGE1-stimulated cAMP accumulation after pertussis toxin treatment for each patient. This compar- [] CONTROL M,CHF reported increases in pertussis toxin substrates (Gi) in the hearts of patients with idiopathic cardiomyopathy with no change in cholera toxin substrates. 6, 8, 9 In patients suffering from ischemic cardiomyopathy, pertussis toxin substrates were reported to decrease.21 Using antibody techniques, Ransnas et a17 found a small reduction of G, in a small number of patients with idiopathic CHF. In an animal model of idiopathic heart failure, the cardiomyopathic hamster, Gs activity appears to be reduced, because the activation of adenylyl cyclase by NaF, forskolin, and isoproterenol is decreased and because muscle membranes from these animals show less Gs activity when reconstituted in cyc-S49 cells (that lack Gs) than those from control hamsters. However, the amounts of G, (as quantified by Western blot analysis), of mRNA for Gs, and of pertussis toxin substrates are not reduced in the hearts of these hamsters.10 Thus, most findings suggest that the ratio of G, to Gi is decreased in failing hearts, but it cannot yet be determined whether numerical and functional alterations of G, or Gi are involved.5-10 This controversy partly stems from an uncertainty whether ADP ribosylation is an assay for the number or for the functional state of G proteins. 22 We have developed a new, simple method to assess the functional state of pertussis toxin substrates in cells from patients. To eliminate a possible inhibitory effect of Gi-like proteins on cAMP generation, we treated intact MNL with pertussis toxin. This treatment completely ribosylated pertussis toxin substrates in MNL, because no additional ADP ribosylation could be detected by further addition of fresh pertussis toxin to MNL membranes. Because treatment of MNL with pertussis toxin did not alter the basal or isoproterenol-and PGE1-stimulated cAMP generation in MNL from normal subjects, pertussis toxin substrates do not appear to exert a major tonic inhibitory effect on adenylyl cyclase in the MNL of healthy people. Basal and isoproterenol-stimulated cAMP accumulations, which are small, were also not significantly altered by pertussis toxin treatment in the group of patients with CHF. PGE1-stimulated cAMP generation, however, which was considerably larger even in the absence of treatment with pertussis toxin, was significantly increased after pertussis toxin treatment in patients with CHF. These data suggest that cAMP generation in MNL from in vitro patients with CHF is under a greater tonic inhibitory influence of Gi than are cells from normal subjects.
Our Because MNL are an extracardiac tissue, their usefulness may be limited as a model to study possible alterations in the myocardium. The possible pitfalls of using MNL for monitoring cardiac f3-adrenergic receptors were recently discussed. 24 The interpretation of ADP ribosylation assays of circulating lymphocytes is also compromised because circulating MNL are composed of different subsets that vary in their cAMP responsiveness to various agents and thus probably have quantitatively different cAMP generating systems. This is important because numerous acute and chronic conditions including CHF25 can alter the subset composition of circulating lymphocytes. Our method of assaying the effect of pertussis toxin treatment of intact cells on cAMP generation is much less sensitive to alterations of the subset composition of circulating MNL, because the same cells are used in toxin-treated and control experiments. More positively, our data point to the intriguing possibility that coupling of receptors to adenylyl cyclase in CHF patients might be altered not only in the myocardium but also in other tissues. Several lines of evidence support this speculation. 1) We have found that after dynamic exercise cAMP generation in response to isoproterenol and to PGE is elevated in MNL of healthy controls but blunted in MNL of CHF patients. 26 2) A marked reduction of cholera toxin substrates in the MNL of CHF patients was recently reported by Horn et a127; the reason for the discrepancy between these findings and the present data is not clear and might be related to methodological differences in the ribosylation protocols.
3) The activity of G, in the cardiomyopathic hamster is decreased not only in the myocardium but also in skeletal muscle.10 Thus, an alteration of receptor signal transduction system in extracardiac tissues of CHF patients appears to be likely. The 
